Rheumatoid Arthritis Treatment Market

View All

Rheumatoid Arthritis Key Trends and Emerging Therapies
Which Key Player Holds the Potential to Corner the Rheumatoid Arthritis Therapeutics Market?

Rheumatoid Arthritis (RA) is a chronic, inflammatory autoimmune disease that leads to progressive and destructive polyarthritis and affects approximately 1% of the population. It is characterized by chronic pain and joint destruction that usually progress from distal to more proximal joints.  DelveInsight ...

Find More

Rheumatoid arthritis market | Rheumatoid arthritis treatment market | Rheumatoid arthritis market | Rheumatoid arthritis drug pipeline
Fierce Competition Lies Ahead for Pipeline Therapies in the Rheumatoid Arthritis Market

The past decade experienced a lot of shuffling in the Rheumatoid arthritis (RA) market. The journey started with the approvals of disease-modifying anti-rheumatic drugs (DMARDs). Several conventional DMARDs constituting methotrexate, leflunomide, hydroxychloroquine, and sulfasalazine, biologics with initial entrant...

Find More

Rheumatoid arthritis treatment market
The Present Rheumatoid Arthritis Treatment Market Offers a Mix-and-Match Approach

Beyond the shadow of a doubt, the Rheumatoid arthritis (RA) treatment market has witnessed strides of improvements during the last few years. There was a time when the treatment for RA was confined to Non-steroidal anti-inflammatory drugs (NSAIDs) and steroids, which could only address pain and swelling. However, t...

Find More